IP Library Granted Patent US 8,026,395
Granted Patent B1
US 8,026,395 · App. 12/454,997 · Granted Sep 27, 2011

Process for the synthesis of anti-neoplasia agent VNP40101M

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,026,395
App. No.
12/454,997
Granted
Sep 27, 2011
Kind
B1
Abstract

The present invention relates to simple, safe, high-yield methods of synthesizing VNP40101M, 1,2-bis(methylsulfonyl)-2-(2-chloroethyl)-2-(methylaminocarbonyl)hydrazine, an anti-neoplasia agent. One particularly preferred method uses methyl chloroformamide in a one-pot reaction at elevated temperatures to provide VNP40101M in high yield.

Claims (21)

1. A method for producing a compound of the formula:

comprising subjecting a compound of the formula:

to a chloroformylating reaction to produce a reactive intermediate of the formula

which is subjected to a methylaminylating reaction to produce VNP40101M, said method optionally further purifying VNP40101M to a purity higher than 97% by subjecting said VNP40101M produced to at least one round of ethanol solubilization and crystallization.

2. The method according to claim 1 where the chloroformylating agent is phosgene.

3. The method according to claim 1 where the chloroformylating agent is trichloromethylchloroformate (triphosgene).

4. The method according to claim 1 where the chloroformylating agent is bistrichloromethylcarbonate (diphosgene).

5. The method according to claim 1 for producing a compound of the formula:

at a purity higher than 97% by subjecting said compound produced according to the method of claim 1 to one or more than one ethanol rounds of solubilization and crystallization steps.

6. A method for producing a compound of the formula:

comprising subjecting a compound of the formula:

to a reaction with ClCONHMe to produce VNP40101M, said method optionally further purifying VNP40101M to a purity higher than 97% by subjecting said VNP40101M produced to at least one round of ethanol solubilization and crystallization.

7. The method according to claim 6 wherein VNP40101M is produced at a purity higher than 97% by subjecting said VNP40101M to at least one round of ethanol solubilization and crystallization.

8. A method for producing a compound of the formula:

comprising subjecting a compound of the formula:

to a reaction with ClC(O)OR to produce a carbamate of the formula:

which is subjected to a methylaminylating reaction containing methylamine and a Lewis acid to produce VNP40101M, said method optionally further purifying VNP40101M to a purity higher than 97% by subjecting said VNP40101M produced to at least one round of ethanol solubilization and crystallization.

9. The method according to claim 8 where the R in ClC(O)OR is an alkyl.

10. The method according to claim 8 where the R in ClC(O)OR is an aryl.

11. The method according to claim 8 for producing a compound of the formula:

at a purity higher than 97% by using one more than one rounds of ethanol solubilization and crystallization steps.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 2, 2011
From: VION PHARMACEUTICALS, INC.
To: NANOTHERAPEUTICS, INC.
Reel/Frame 026206/0775 →